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Abstract: 
Solid Pseudopapillary Neoplasm (SPN) of the pancreas represents 1-3 % of all exocrine pancreatic tumors and is uncommon in children. 
We report four pediatric patients with SPN where each patient posed a unique diagnostic and therapeutic challenge. We describe these 
four cases with detailed clinical-radiological-pathological correlations. All patients are female, with a median age 13.5 years. Two 
patients presented with abdominal pain, one with jaundice and one with an incidental pancreatic mass on abdominal CT scan. 
Radiological studies included abdominal ultrasound, CT scan and MRI of abdomen. Pancreaticoduodenectomy was performed in three 
patients and laparoscopic distal pancreatectomy in one patient. Mean tumor size was 4.5 cm (ranged from 1.9 to 11.5 cm). All SPNs 
were benign on histological exam. One patient developed pancreatic insufficiency post-surgery. No tumor recurrence was observed 
over a mean follow up period of 1 year. We conclude that diagnosis of SPN in pediatric population can be challenging due to non-
specific clinical findings, and surgical removal of the tumor is usually required for definitive histologic diagnosis and treatment. Most 
tumors are benign and recurrence is very rare.  
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Introduction: 
 
Solid pseudopapillary neoplasm of the pancreas (SPN) is an uncommon 
tumor of pancreas, accounting for 1-3 % of all exocrine pancreatic tumors 
[1-3]. It was first described by Frantz in 1959 [4, 5]. Since then it has been 
known by different names such as solid and papillary epithelial neoplasm, 
papillary cystic neoplasm, solid and cystic papillary neoplasm, but in 
1996, the World Health Organization (WHO) designated it as SPN [6, 7]. 
As a result of broader use of cross-sectional imaging and better 
recognition of tumor, there has been a 7-fold increase in the number of 
SPN cases since 2000 [8,9]. These tumors are mostly of benign nature but 
5-15% of SPNs are malignant and liver is the most common site of 
metastasis [10-14]. Although tumor can occur in all races, Asian and 
African-American female in their second or third decade of life (mean age 
22 to 36.5 years) are most commonly affected with female to male ratio 
of 10:1 [4, 6, 10, 15]. A typical SPN is a well-encapsulated mass with 
solid and cystic components due to varying degrees of internal 
hemorrhage and necrosis [5, 7]. They are predominantly located in the tail 
(43%) followed by the head (25%) and the body (13%) of pancreas [16, 
17]. These tumors are either found incidentally on imaging studies or 
present with vague abdominal symptoms or mass [1, 4]. Surgical 
resection is the mainstay of treatment [3]. Overall 5-year survival rate 
after resection is 90-98%, including patients with metastatic disease [17, 
18]. Rarely, patients receive adjuvant chemotherapy for very large or 
malignant tumors [17]. We are reporting four pediatric cases of SPN 
where each patient had a distinct clinical presentation and posed a 
diagnostic challenge. 
 
Method: 
 
We retrospectively reviewed our institutional database to identify patients 
with SPN from January 2010 to December 2018 and correlated 
demographic, clinical, radiological, pathological and surgical details.  
 
Results: 
 
CASE 1: 
 
A previously healthy 14-year-old Hispanic female was admitted with one 
week of constant, non-radiating, stabbing right upper quadrant abdominal 
pain (RUQ) with a severity of 6-7/10. For the past few months, she had 
sour taste in mouth associated with nausea 3 to 4 times per week but no 
vomiting. Stools were regular and brown. Physical examination showed 
RUQ and epigastric tenderness with no palpable mass or 
hepatosplenomegaly. Initial abdominal ultrasound (US) was concerning 
for "a mass in her stomach" and elevated liver enzymes. She was then 
referred to our hospital for further management. Her laboratory testing 
results were summarized in table 1.  
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 Case One Case Two Case Three Case Four Reference 
AST (units/L) 147 259 78 25 17-64 
ALT (units/L) 195 387 36 17 12-48 
Total Bilirubin (mg/dL) 0.6 8.3 0.7 0.5 0.3-1.2 
Direct bilirubin (mg/dL) 0.1 4.3 0.1 N/A 0.1-0.5 
GGT (units/L) 16 1151 N/A 31 7-76 
Total protein (g/dL) 7.9 8.9 6.9 6.8 6.1-7.7 
Albumin (g/dL) 4.0 5.1 4.5 4.4 3.8-5.2 
INR (Ratio) 1.2 1.1 N/A 1.1 0.9-1.2 
Lipase (units/L) 15 83 267 28 9-65 
Amylase (units/L) 23 111 188 49 25-109 
 
Table 1. Relevant Serum Laboratory Testing Results at the time of Presentation 
AST, Aspartate aminotransferase; ALT, Alanine aminotransferase; GGT, Gamma-glutamyl transferase; INR, International Normalized Ratio; N/A, not 
available 
 
Abdominal computed tomography (CT) and magnetic resonance imaging 
(MRI) with contrast showed a large retroperitoneal mass. Because of the 
uncertainty of the origin of the mass, open laparotomy and biopsy of the 
mass without excision was performed followed by a trial of Gemcitabine 
with the intention to shrink the tumor. She underwent modified Whipple 
procedure (pancreaticoduodenectomy) after no significant decrease in 
size after 2 cycles of Gemcitabine by repeat abdominal CT. The surgery 
was uneventful and she was discharged home on post-operative day 7. 
She developed chronic pancreatic insufficiency 3 years post-surgery, for 
which she was started on pancreatic enzyme replacement therapy, 
Aquadeks, and Vitamin D, otherwise, she had no recurrence or metastasis 
of the tumor with annual abdominal CT for 5 years.  
 
Radiological features: Initial abdomen and pelvis CT showed a large 
complex, non-invading, well-circumscribed right retroperitoneal mass 
with areas of enhancement and nodularity within its rim. There was a 
mass effect on the adjacent duodenum, kidney, liver and portal vein 
without obstruction. A few small lymph nodes were also seen in the 
retroperitoneum. Origin of the mass was not very clear on CT scan but 
was most concerning for cystic pancreatic mass. To better delineate the 
mass, MRI of abdomen and pelvis with contrast was obtained which also 
showed a cystic and peripherally solid mass (11.5 x 11.4 x 4.4 cm) with 
late peripheral nodular enhancement and multiple blood-blood fluid 
levels of differing stages (Figure 1A-1C).  
The exact epicenter of this mass was difficult to locate; however, it was 
thought to arise from the potential Morison's pouch, which would suggest 
a sarcoma. However, intimate association with the adjacent pancreatic 
head also raised the concern for a solid pseudopapillary neoplasm, 
pancreatoblastoma, or exophytic fibrolamellar hepatocellular carcinoma. 
 
Pathological findings: The initial biopsy showed sheets of cohesive 
tumor cells arranged around fibrovascular cores, forming a 
pseudopapillary architecture. The tumor cells were bland with a moderate 
amount of eosinophilic cytoplasm and relatively uniform nuclei, fine 
chromatin, and inconspicuous nucleoli (Figures 1D-1E). There was no 
mitosis or necrosis. The tumor cells were strongly positive for beta-
catenin (diffuse) (Figure 1F), CD10 (diffuse) (Figure 1G), anti-alpha 1 
trypsin (focal), and weakly positive for synaptophysin. The overall 
features were consistent with a diagnosis of SPN. The resected tumor was 
located in the pancreatic head, measuring 10.5 x 10.5 x 10.5 cm. It was 
well-circumscribed, hemorrhagic, with multiple irregular cystic spaces 
and necrotic debris on cut surfaces.  The histopathological features of the 
resected tumor was similar to that seen in the initial biopsy, except there 
were signs suggestive of treatment effect, including fibrosis, various 
degrees of vessel hyalinization, and hemosiderin. Although the tumor 
grossly appeared to be well-circumscribed, microscopically, it showed an 
infiltrative border with the surrounding pancreatic tissue. 
 
 
Figure 1: Radiology and Pathology of case 1 
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A: Axial T2 MRI image shows a mixed signal mass with small peripheral cystic structures involving the head of the pancreas. There is coexistent 
compression of the gallbladder and the right kidney. B: A coronal post-contrast CT image of the abdomen shows a hypodense mass involving the 
pancreatic head. There is additional compression of the portal vein, gallbladder, and bowel loops. C: Coronal post-contrast T1 MRI image of the abdomen 
shows a hypoenhancing mass in the pancreatic head. There is concomitant compression of the adjacent bowel loops. D: Microscopic picture of tumor 
(H&E stain): The tumor shows pseudopapillae with fibrovascular cores, lined by several layers of bland epithelial cells with eosinophilic cytoplasm. E: 
Microscopic picture of tumor (H&E stain): The cells are bland with a moderate amount of eosinophilic cytoplasm and relatively uniform nuclei, fine 
chromatin, and inconspicuous nucleoli. F: Microscopic picture of tumor (beta-catenin immunohistochemical stain): Diffusely positive nuclear and 
cytoplasmic staining. G: Microscopic picture of tumor (CD10 immunohistochemical stain): Diffusely positive nuclear and cytoplasmic staining. 
 
CASE 2: 
 
An 11-year-old, previously healthy African-American female was 
observed to have jaundice by her dentist during a routine dental 
examination. She subsequently come to our hospital for further care. She 
recalled that she did have mild upper abdominal discomfort, dark brown 
urine, and light tan stools for a few days; otherwise, she had no itching, 
nausea, vomiting, dysphagia, heartburning, constipation, diarrhea, and 
weight loss. She denied taking any medications. Physical examination 
showed jaundice but no hepatosplenomegaly. Her laboratory testing 
results are summarized in table 1. Abdominal US, CT, and MRI showed 
a large mass at the pancreatic head. Clinical differential diagnoses 
included rhabdomyosarcoma, SPN, and others. The patient underwent 
surgery and had a pancreaticoduodenectomy after intraoperative frozen 
section ruled out rhabdomyosarcoma that would need neoadjuvant 
therapy instead of first stage resection. She had no perioperative 
complications and was discharged home on post-operative day 6. On a 
follow up visit 2 weeks later, she recovered well with resolution of her 
jaundice and abdominal discomfort. She subsequently moved to another 
state and was lost to follow up.  
 
Radiological features: CT abdomen revealed a well-defined (5.3 cm 
x 6.2 cm x 5.6 cm) mass with mixed solid and cystic components in the 
region of the head of the pancreas with a thin peripheral rind of tissue and 
no calcifications. The mass lesion was causing obstruction of the distal 
common bile duct (CBD) with dilation of the intra and extra-hepatic ducts 
as well as the gallbladder with layering sludge. MRI of abdomen also  
 
 
revealed a large heterogeneous rounded mass in the region of the head of 
the pancreas/proximal duodenum with T1 signal intensity suggesting a 
small amount of blood products. Delayed imaging showed mild 
progressive enhancement suggesting a fibrous or solid/soft tissue 
component. Again, compression and dilation of CBD and main pancreatic 
duct was seen. Mild compression of portal vein and inferior vena cava 
(IVC) without obstruction was also visualized. There were few scattered 
mesenteric and periaortic lymph nodes (Figure 2A-2B). Differential 
diagnosis included intraductal papillary mucinous neoplasm (IPMN), 
serous or mucinous cystic neoplasm, and solid pseudopapillary neoplasm. 
 
Pathological findings: The intraoperative frozen section showed an 
epithelioid tumor with papillary structure, suggestive for SPN. The 
resected tumor was well-circumscribed and partially encapsulated. It was 
located in the pancreatic head, measuring 6.5 x 6.5 x 4.5 cm. Sectioning 
revealed a red-tan, solid and cystic tumor with hemorrhage and edematous 
changes (Figures 2C).  Microscopically, the tumor showed groups of 
discohesive tumor cells arranged in a pseudopapillary fashion with 
prominent hemorrhage and cystic changes (2D). The tumor cells had a 
moderate amount of eosinophilic cytoplasm and relatively uniform nuclei, 
fine chromatin, and inconspicuous nucleoli; some of the tumor cells show 
clear cell changes (Figure 2E). There was no mitosis or necrosis. 
Multifocal perineural and lymphovascular invasion was observed, but no 
definitive invasion into the muscular vessels was identified (Figure 2G-
2H). Immunohistochemical stains showed strongly positivity for beta-
catenin (diffuse), CD10 (focal), and alpha-1 antitrypsin (rare cells).  The 
overall findings were diagnostic for SPN. 
 
 
 
Figure 2: Radiology and Pathology of case 2 
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A: Axial T2 image of the upper abdomen shows a mixed signal intensity mass arising from the head of the pancreas. There is additional dilation of the 
pancreatic duct. B: Axial T1 postcontrast MRI image shows an irregularly enhancing mass at the head of the pancreas. There is compression of the IVC 
and the portal vein at the level of the porta hepatis. C: Gross picture of the pancreatic head containing the tumor that measures 6.5 x 6.5 x 4.5 cm. The 
residual pancreas can be seen (Stars indicating benign residual pancreatic tissue). D: Microscopic picture of tumor (H&E stain): The tumor shows groups 
of discohesive tumor cells arranged in a pseudopapillary fashion with prominent hemorrhage and cystic changes. E: Microscopic picture of tumor (H&E 
stain): Some of the tumor cells show clear cell changes. 
 
CASE 3: 
 
A 13-year-old Caucasian female developed right lower quadrant 
abdominal pain. Abdominal CT showed an inflamed appendix, which was 
removed laparoscopically at an outside hospital. CT also showed a distal 
pancreatic mass, for which she was referred to our hospital for further 
evaluation after appendectomy. She had no abdominal pain or other 
symptoms during her initial evaluation at our hospital, and her physical 
exam was unremarkable. Laboratory results are summarized in table 1. 
She underwent laparoscopic distal pancreatectomy with an uneventful 
post-operative course and was discharged home on post-operative day 3. 
Follow up MRI of abdomen 8 months later did not reveal any recurrence 
of the tumor, and her lipase and amylase normalized.  
 
Radiological features: CT and MRI of abdomen revealed low 
density, hypo-enhancing mass in the area of pancreatic tail with no 
significant mass effect on surrounding structures. Axial ADC map of the 
mass showed a low signal intensity reflecting tumor hypercellularity and 
a high suspicion of SPN (Figure 3A-D).  
 
Pathological findings: The distal pancreatectomy showed a well-
circumscribed, non-encapsulated, solid mass measuring 2.2 x 2.0 x 1.9 
cm. It had a lobulated, yellow tan cut surface with an apparent central 
scar. The tumor was located in the tail of pancreas (Figure 3E).  
Microscopically, the tumor was composed predominantly of solid areas 
with focal pseudopapillary structures (Figures 3F-3G). There were pale 
areas composed of cells with clear cytoplasm and mucinous secretions. 
Intracytoplasmic hyaline globules were also appreciated in multiple areas 
(Figure 3H). The distal residual pancreatic parenchyma showed atrophic 
changes with diminished exocrine acini, but preserved islets of 
Langerhans. The tumor invaded into the pancreatic parenchyma and 
showed perineural invasion. The tumor cells were positive for beta-
catenin (diffuse), CD10 (diffuse), alpha-1 antitrypsin (multifocal focal), 
and vimentin (diffuse) and negative for chromogranin, synaptophysin, 
and pan-cytokeratin. The overall findings were diagnostic for SPN.  
 
Figure 3: Radiology and Pathology of case 3 
 
A: Axial T2 MRI image shows a mildly hyperintense mass in the pancreatic tail. B: Axial ADC map at the level of the pancreas shows a low signal intensity 
pancreatic tail mass reflecting tumor hypercellularity. C: Axial post-contrast CT image of the upper abdomen shows a low-density pancreatic tail mass. 
D: Axial postcontrast T1 MRI image of the upper abdomen shows a hypoenhancing pancreatic tail mass. E: Gross picture of the pancreatic tail containing 
the tumor that measures 2.2 x 2.0 x 1.9 cm. The tumor has lobulated, yellow-tan cut surfaces with an apparent central scar (arrow indicating the central 
scar). F: Microscopic picture of tumor (H&E stain): Solid nests of poorly cohesive cells are seen. G: Microscopic picture of tumor (H&E stain): Sheets of 
cohesive tumor cells arranged around a fibrovascular core forming pseudopapillary architecture. H: Microscopic picture of tumor (H&E stain): 
Intracytoplasmic hyaline globules are seen in multiple areas (arrows are indicating the hyaline globules). 
 
CASE 4: 
 
A 14 year-old- Caucasian female presented with sudden onset of 
epigastric pain and non-bilious, non-bloody vomiting after she was 
“elbowed in the abdomen” during a soccer game. She had a significant 
clinical history of a similar blunt abdominal trauma during a basketball 
game with gradually worsening epigastric pain and vomiting two years 
earlier, for which she had a CT scan suspected for pseudo cyst of the 
pancreatic head at an outside hospital and received drainage by 
interventional radiology; the aspirate yielded a small volume of bloody 
aspirate (no tissue was obtained for histopathological examination at the  
 
time) with subsequent reduction in the size of the mass and improvement 
in her abdominal pain. She was discharged with a diagnosis of 
questionable intra-abdominal hematoma, most likely duodenal 
hematoma. She was followed by serial abdominal ultrasounds at outside 
hospital, which reportedly showed gradual reduction in the size of the 
mass, seemed to be expected in a patient with a resolving hematoma. She 
had no abdominal symptoms over the following two years, until current 
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presentation. At current presentation, physical examination revealed a 
sick-looking patient in moderate pain. Her abdomen was severely tender 
to palpation in the epigastric area with hypoactive bowel sounds. 
Abdominal US, CT scan, and MRI revealed heterogeneous mass with 
scattered calcification between the pancreatic head and proximal 
duodenum, raising suspicions for a pancreatic tumor at the same location 
with similar radiological features as seen two years ago. Her laboratory 
testing results at this admission are summarized in table 1.  She had fine 
needle aspiration (FNA) revealed 20 ml of serosanguineous fluid and a 
core tissue biopsy. Subsequently, she underwent a 
pancreaticoduodenectomy.  Post-operatively, she suffered intra-
abdominal fluid collections that required drainage and antibiotics. Repeat 
MRI 6 months later did not show recurrence of the tumor.  
 
Radiological features: Abdominal US revealed a heterogeneous 
mass in RUQ measuring 9 x 5 x 7 cm, that increased in size from the 
ultrasound 2 years ago. MRI of the abdomen also showed a prominent 
heterogeneous mass with areas of hemorrhage and cystic change with 
some calcifications, interposed in the region between the pancreatic head 
and proximal duodenum with a mass effect upon the pancreatic head, 
proximal duodenum, upper abdominal IVC and the extrahepatic portal 
vein (Figure 4A-4B). The epicenter of the mass was difficult to discern. 
There was mild dilatation of the CBD. Differential considerations 
included SPN or a complex hematoma arising from duodenum or the     
groove between the pancreatic head and the duodenum.  
 
Pathological findings: FNA showed few large clusters of epithelioid 
cells with rare associated fibro-vascular structures (Figure 4C-4D). The 
core biopsy also showed fibro-connective tissue with a neoplastic 
proliferation consisting of fibro-vascular cores, with a small amount of 
associated myxoid stromal changes, surrounded by the oval epithelioid 
cells. Intracytoplasmic hyaline globules were also appreciated and were 
highlighted by Periodic Acid-Schiff stain after diastase treatment (PASD) 
(Figures 4E-4F). The cells were positive for beta-catenin (focal) and 
CD10 (diffuse).  These features were diagnostic for SPN.  The resected 
specimen showed a well-circumscribed mass located in the head of the 
pancreas, measuring 6.5 x 4.5 x 4.3 cm. It was solid and cystic with 
hemorrhage and calcification on cut surfaces (Figure 4G). Microscopic 
examination showed similar histological features and consistent with the 
diagnosis of SPN. There were prominent hemorrhagic cystic changes as 
well as calcification and hemosiderin deposition. Perineural invasion was 
present, but lymph-vascular invasion was absent. The uninvolved residual 
distal pancreatic parenchyma showed atrophic changes with fibrosis and 
diminished exocrine glands. 
 
 
Figure 4: Radiology and Pathology of case 4 
 
A: Coronal T2 MRI image shows a mixed signal intensity mass in the pancreatic head creating mild dilation of the common duct. B: Axial post-contrast 
T1 image of the upper abdomen shows a modestly enhancing mass in the pancreatic head with compression of the duodenum and the gallbladder. C: 
Microscopic picture of tumor (Diff-Quick stain): Clusters of epithelioid cells with rare associated fibro-vascular structures. D: Microscopic picture of tumor 
(PAP stain): Tumor cells with eosinophilic cytoplasm with large and uniform nuclei, inconspicuous nucleoli and rare grooves. D: Microscopic picture of 
tumor (H&E stain): Tumor with fibro-vascular cores. Intracytoplasmic hyaline globules are seen. F: Microscopic picture of tumor (PASD stain): 
Intracytoplasmic hyaline globules are highlighted by Periodic Acid-Schiff stain after diastase treatment (PASD) and are indicated with arrows. G: Gross 
picture of the pancreatic head containing the tumor that measures 6.5 x 4.5 x 4.3 cm. 
 
Discussion: 
 
Our report focuses on the variable clinical presentation of SPN, which can 
be very challenging to diagnose at times, and reviews the radiological and 
pathological differentials of SPN. SPN comprises 1-3% of all pancreatic 
tumors and affects young female with a mean age of 22-36.5 years (2-74 
years). Asian and African-American races show higher incidence of the 
disease, with a female to male ratio of 10:1.  Consistent with the 
epidemiologic data, our reported cases are all female teenagers in their 
second decade. 
The pathogenesis and origin of SPN is still unclear. A somatic point 
mutation has been noticed in CTNNB1, which is the gene encoding for  
 
beta-catenin in Wnt singling pathway. This mutation leads to 
condensation of beta-catenin and cyclin-D1 in the nucleus [19]. The loss 
of E-cadherin expression on cellular membranes of neoplastic cells has 
also been attributed to this gene mutation, leading to discohesiveness of 
tumor cells and the resulting pseudopapillary architecture [20]. 
 
SPNs can present in a variety of ways. Most SPNs are found incidentally 
on routine imaging studies or physical examination as an abdominal mass 
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in an otherwise asymptomatic individual. Sometimes, patients present 
with severe abdominal pain after suffering blunt abdominal trauma, and 
tumor is found on imaging [14]. Other symptoms can happen due to 
compression of the surrounding structures by the tumor. Jaundice is rare 
but sometimes SPN of head of pancreas can cause jaundice and elevated 
liver enzymes [10]. Of note, every patient in our report presented with 
different chief complaint, which highlights the variable clinical 
expression of this tumor.  
 
SPN can be detected by abdominal US, CT, MRI or PET scan. On CT, 
SPN appear as a well-defined, heterogeneous, hypoattenuating mass with 
variable solid and cystic components4. MRI, however, can better 
differentiate between solid and cystic components [7]. Sometimes, areas 
of calcification may be present at the periphery. Cystic components are 
mostly centrally located. Endoscopic ultrasound guided fine needle 
aspiration (EUS-FNA) is another modality to obtain preoperative 
diagnosis for solid and cystic pancreatic lesions [21]. Aspirated fluid 
shows low amylase and low CEA (carcinoembryonic antigen), which can 
be helpful in differentiating it from other cystic structures [22]. Biopsy 
diagnosis of SPN is confirmed by curative resection.   
 
On gross examination, SPN appears as well circumscribed, encapsulated 
solid mass with varying degrees of central necrosis and hemorrhage that 
corresponds to cystic component on imaging [15,23]. Histologic findings 
demonstrate uniform polyhedral cells lining small-hyalinized 
fibrovascular stalks.  Between the pseudopapillae, degenerative changes, 
foamy histiocytes, and erythrocytes may be seen, along with hyalinized 
and focally calcified connective tissue and cholesterol crystals. Round to 
oval nuclei with occasional grooves and convolutions are typical. 
Nucleoli are faint, and mitoses are infrequent.  Intracellular and 
extracellular metachromatic hyaline globules may also be seen [24]. 
Special stains demonstrate diffuse positivity for nuclear and cytoplasmic 
beta-catenin and neuron specific enolase (NSE) and vimentin, with focal 
intense small clusters or single cell staining for alpha-1-antitrypsin and 
alpha-1-antichymotrypsin [25].  CD10, vimentin, and DOG1 (discovered 
on gastrointestinal stromal tumor 1) are often positive, suggesting a 
possible centroacinar cell origin [26].  CD117, CD56, and galectin-3 may 
be expressed, as well as progesterone receptors, alternately suggesting 
derivation from genital ridge/ovarian anlage related cells attached during 
embryogenesis to the pancreas [27].   Various other epithelial markers, 
neuroendocrine markers, pancreatic enzymes, islet cell hormones, CEA, 
and CA19.9 have been described, prompting a third theory of origin from 
primitive pancreatic cells with potential for endocrine and exocrine 
differentiation [28]. 
 
The differential diagnosis for SPN includes pancreatoblastoma, 
pancreatic endocrine neoplasm, pancreatic pseudocyst, serous 
cystadenoma, mucinous cystic neoplasm [29]. Pancreatoblastoma is a 
very uncommon pediatric pancreatic neoplasm, usually occurs in children 
younger than 5 years old. Histologically, it consists of solid sheets and 
nests of uniform epithelial cells mixed with occasional acinar and ductal 
structures and characteristic squamoid corpuscles. A 50% cure rate with 
excision is seen in infants, although prognosis is worse in adults [30]. 
Pancreatic endocrine neoplasms occur at any age but are rare in 
childhood. It is often associated with multiple endocrine neoplasia 
syndrome type 1 (MEN1). Some tumors may secrete pancreatic 
hormones, which are referred as functional tumors.  Microscopically, the 
tumors are comprised of nests of polygonal cells with salt-and-pepper 
chromatin. Positive staining may be noted for chromogranin, 
synaptophysin, peptides, insulin, glucagon, somatostatin, pancreatic 
polypeptide, gastrin, vasoactive intestinal polypeptide, or CEA, but 
nuclear staining for beta-catenin is negative. Pancreatic psuedocysts are 
the most common type of pancreatic cystic lesion and are more frequent 
in alcoholic males. Clinically, the patients may have high amylase and 
low CEA [22]. FNA biopsy reveals predominately necrotic debris, 
macrophages, rare epithelial cells, and absent mucin. Histologically, it is 
easily to be differentiated from SPN by its lacking epithelial linings. 
Serous cystadenoma is a benign neoplasm presenting as multiple (>6), 
small (<2cm) cysts in the pancreatic head of elderly females. An 
association with von Hippel-Lindau syndrome may be seen. FNA shows 
watery content with a few bland cuboidal cells, no mucin or debris, 
positivity for glycogen and histology shows small cystic spaces lined by 
small cuboidal cells with clear cytoplasm (glycogen) and minimal mucin. 
It may show positive membranous staining for beta-catenin, but nuclear 
and cytoplasmic beta-catenin staining that is typically seen in SPN is 
absent [31]. Mucinous cystic neoplasm of the pancreas is a rare lesion 
found in middle age females.  It consists of large cyst lined by intestinal, 
pseudopyloric or gastric foveolar type epithelium that often form papillae, 
surrounded by characteristic dense ovarian type stroma. It is distinguished 
from SPN by its true epithelial lining of the cyst.   
 
Although most SPN are of benign nature, about 5-10% exhibit malignant 
potential with metastasis and happens commonly in male patients [32]. 
Malignant tumors tend to be larger in diameter (>10cm) and contain larger 
solid portion as compared to benign SPN. Some other characteristic 
features of malignant SPN include pancreatic tissue infiltration, focal 
capsular invasion, perineural, vascular or adjacent organ invasion, and 
metastasis [16]. The most common sites of metastasis are liver, spleen, 
regional lymph nodes and mesentery [11]. Some rare sites of metastasis 
are lung and stomach [12].   
Curative resection of tumor is the mainstay of treatment, even in patients 
with malignant and metastatic SPN [6]. Different surgical procedures 
have been performed depending upon the location of the tumor. 
Pancreaticoduodenectomy or Whipple procedure is used to resect SPN on 
head of pancreas, and distal pancreatectomy is done for tumors limited to 
the tail of pancreas. Prophylactic splenectomy has also been performed in 
cases where tumor invades the splenic vasculature [3]. Post-surgical 
complications may include chronic pancreatic insufficiency, pancreatic 
fistula, intra-abdominal abscess, and gastric fistula [33]. Enucleation of 
the tumor is also an option, has much lower morbidity than 
pancreaticoduodenectomy, and offers a chance to preserve of endocrine 
and exocrine function [9]. Although, their role in overall prognosis is not 
yet well established, certain chemotherapeutic agents like cisplatin, 5-FU, 
and gemcitabine have been used in an attempt to shrink very large tumors 
or tumors with malignant features [17].  
The post-operative recurrence is 10-15% and certain high risk features 
(tumor size > 5cm, lympho-vascular invasion, lymph node metastasis, 
synchronous metastasis and positive tumor margin) are associated with 
postoperative recurrence of SPN [3, 8, 33]. Most of the relapses occur 
more than 5 years after resection; therefore, follow-up should be 
continued > 5 years in patients with high risk features [8]. Overall 5-year 
survival rate after resection is >95%, even in patients with metastatic 
disease [34]. 
Conclusion: 
In conclusion, SPN is a rare tumor in pediatric patients and can pose 
certain diagnostic and therapeutic challenges due to its location and risk 
of morbidity with surgical removal. It has very low malignant potential 
with excellent survival rate after resection.  
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